These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 27012594)

  • 1. Dysbiosis in intestinal inflammation: Cause or consequence.
    Buttó LF; Haller D
    Int J Med Microbiol; 2016 Aug; 306(5):302-309. PubMed ID: 27012594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
    Fritsch J; Abreu MT
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The resilience of the intestinal microbiota influences health and disease.
    Sommer F; Anderson JM; Bharti R; Raes J; Rosenstiel P
    Nat Rev Microbiol; 2017 Oct; 15(10):630-638. PubMed ID: 28626231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
    Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
    Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The human gut microbiota: Interactions with the host and dysfunctions].
    Lepage P
    Rev Mal Respir; 2017 Dec; 34(10):1085-1090. PubMed ID: 28506730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gut pathobiont synergizes with the microbiota to instigate inflammatory disease marked by immunoreactivity against other symbionts but not itself.
    Gomes-Neto JC; Kittana H; Mantz S; Segura Munoz RR; Schmaltz RJ; Bindels LB; Clarke J; Hostetter JM; Benson AK; Walter J; Ramer-Tait AE
    Sci Rep; 2017 Dec; 7(1):17707. PubMed ID: 29255158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping.
    Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A
    J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
    Ray A; Dittel BN
    Immunology; 2015 Nov; 146(3):359-68. PubMed ID: 26211540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot?
    Shapiro JM; Cho JH; Sands BE; LeLeiko NS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):842-6. PubMed ID: 25725444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut.
    Buttó LF; Haller D
    Gut Microbes; 2017 Jan; 8(1):53-58. PubMed ID: 28102757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease.
    Lopez LR; Ahn JH; Alves T; Arthur JC
    Front Cell Infect Microbiol; 2022; 12():934619. PubMed ID: 35959366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.